公开(公告)号：US20230293558A1

公开(公告)日：2023-09-21

申请号：US17903080

申请日：2022-09-06

Applicant: Enveric Biosciences Canada Inc.

Inventor： Jillian M. Hagel ,  Peter J. Facchini

IPC: A61K31/675 ,  A61K31/4045 ,  C12N15/52 ,  C12P17/10 ,  C12N9/12 ,  C12N9/02 ,  C12N9/10

CPC classification number: A61K31/675 ,  A61K31/4045 ,  C12N15/52 ,  C12P17/10 ,  C12N9/1205 ,  C12N9/0083 ,  C12N9/1007

Abstract: Disclosed are novel halogenated psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced using a biosynthetic system which comprises cells comprising a psilocybin biosynthetic enzyme complement.

公开(公告)号：US11707447B1

公开(公告)日：2023-07-25

申请号：US17893122

申请日：2022-08-22

Applicant: Enveric Biosciences Canada Inc.

Inventor： Jillian M. Hagel ,  Kaveh Matinkhoo ,  Peter J. Facchini

IPC: A61K31/4045 ,  C07D209/16 ,  A61P25/00 ,  C07D209/20

CPC classification number: A61K31/4045 ,  A61P25/00 ,  C07D209/20 ,  C07D209/16

Abstract: Disclosed are novel C4-carbonothioate-substituted tryptamine derivative compounds and pharmaceutical and recreational drug formulations containing the same. The pharmaceutical formulations may be used to treat brain neurological disorders.

公开(公告)号：US20230043896A1

公开(公告)日：2023-02-09

申请号：US17903103

申请日：2022-09-06

Applicant: Enveric Biosciences Canada Inc.

Inventor： Jillian M. Hagel ,  Peter J. Facchini ,  Chang-Chun Ling

IPC: C07D209/16

Abstract: Disclosed are novel hydroxylated psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced synthetically or biosynthetically.

公开(公告)号：US20250100967A1

公开(公告)日：2025-03-27

申请号：US18971774

申请日：2024-12-06

Applicant: Enveric Biosciences Canada Inc.

Inventor： Jillian M. Hagel ,  Peter J. Facchini ,  Chang-Chun Ling

IPC: C07D209/16

Abstract: Disclosed are novel hydroxylated psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced synthetically or biosynthetically.

公开(公告)号：US12133856B2

公开(公告)日：2024-11-05

申请号：US18390228

申请日：2023-12-20

Applicant: Enveric Biosciences Canada Inc.

Inventor： Jillian M. Hagel ,  Peter J. Facchini ,  Chang-Chun Ling

IPC: A61K31/675 ,  A61P25/18

Abstract: Disclosed are novel multi-substituent psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced by reacting a reactant psilocybin derivative with a substituent containing compound.

公开(公告)号：US20240246924A1

公开(公告)日：2024-07-25

申请号：US18541304

申请日：2023-12-15

Applicant: Enveric Biosciences Canada Inc.

Inventor： Kaveh Matinkhoo ,  David James Press ,  Jessica Lee ,  Charlie Cai ,  Jillian M. Hagel ,  Peter J. Facchini

IPC: C07D317/60 ,  C07D317/58 ,  C07D317/64 ,  C07D405/06 ,  C07D413/06

CPC classification number: C07D317/60 ,  C07D317/58 ,  C07D317/64 ,  C07D405/06 ,  C07D413/06

Abstract: Disclosed are novel fused mescaline derivative compounds, notably substituted ethylamine fused heterocyclic mescaline derivatives, including substituted ethylamine fused dioxolane mescaline derivatives, and pharmaceutical and recreational drug formulations containing the same. Methods of making and using these compounds are also disclosed.

公开(公告)号：US20240116866A1

公开(公告)日：2024-04-11

申请号：US18510936

申请日：2023-11-16

Applicant: Enveric Biosciences Canada Inc.

Inventor： Jillian M. Hagel ,  Peter J. Facchini ,  Chang-Chun Ling

IPC: C07D209/16

CPC classification number: C07D209/16

Abstract: Disclosed are novel aminated psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The aminated psilocybin derivative compounds may be chemically synthesized.

公开(公告)号：US20230398097A1

公开(公告)日：2023-12-14

申请号：US18227688

申请日：2023-07-28

Applicant: Enveric Biosciences Canada Inc.

Inventor： Jillian M. Hagel ,  Peter J. Facchini ,  Chang-Chun Ling

IPC: A61K31/404 ,  A61P25/18 ,  C07D209/32 ,  C07D209/16 ,  C07D209/30

CPC classification number: A61K31/404 ,  A61P25/18 ,  C07D209/32 ,  C07D209/16 ,  C07D209/30

Abstract: Disclosed are novel carboxylated psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced by reacting a reactant psilocybin derivative with a carboxyl or Carboxylic acid derivative containing compound.

公开(公告)号：US20230357185A1

公开(公告)日：2023-11-09

申请号：US17886075

申请日：2022-08-11

Applicant: Enveric Biosciences Canada Inc.

Inventor： Jillian M. Hagel ,  Ye Cai ,  Kaveh Matinkhoo ,  David James Press ,  Glynnis Elizabeth Jensen ,  Peter J. Facchini

IPC: C07D209/16 ,  C07D403/12 ,  C07D401/12 ,  C07D405/12

CPC classification number: C07D401/12 ,  C07D209/16 ,  C07D403/12 ,  C07D405/12

Abstract: Disclosed are novel C4-carboxylic acid-substituted tryptamine derivative compounds and pharmaceutical and recreational drug formulations containing the same. The pharmaceutical formulations may be used to treat brain neurological disorders.

公开(公告)号：US20230321040A1

公开(公告)日：2023-10-12

申请号：US18203823

申请日：2023-05-31

Applicant: Enveric Biosciences Canada Inc.

Inventor： Jillian M. Hagel ,  Kaveh Matinkhoo ,  Peter J. Facchini

IPC: A61K31/4045 ,  C07D209/20 ,  A61P25/00

CPC classification number: A61K31/4045 ,  C07D209/16 ,  A61P25/00 ,  C07D209/20

Abstract: Disclosed are novel C4-carbonothioate-substituted tryptamine derivative compounds and pharmaceutical and recreational drug formulations containing the same. The pharmaceutical formulations may be used to treat brain neurological disorders.